Accessible testing for the infections may help curb the STI epidemic, but there is still a long way to go. By Laura Baisas Published Nov 28, 2023 3:30 PM EST Get the ...

Last year, the Food and Drug Administration approved the first at-home test that can detect three common infections in women — gonorrhea, chlamydia and trichomoniasis — as well as the first home-based ...

At-home chlamydia tests are a convenient way to test in the comfort of a person’s home. Read on to compare our top picks, including tests for chlamydia in the throat. A person can buy the Simple 2 ...

Credit: LetsGetChecked. The Simple 2 Test can detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae through samples collected at home from vaginal swabs and urine specimens. The Food ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to ...

Background: The National Chlamydia Screening Programme performs 1.7 million tests annually among young adults in England. The effect of chlamydia screening on subsequent behavior is unknown. This ...

Please provide your email address to receive an email when new articles are posted on . The pay-it-forward strategy may increase gonorrhea and chlamydia testing among Chinese men who have sex with men ...

Experts say patients can get results before they leave the doctor’s office, allowing them to start treatments earlier. Share on Pinterest Researchers say the new chlamydia test is just as accurate as ...

In the midst of record-high rates of sexually transmitted infections (STIs or STDs), a new industry-sponsored survey finds that many of those at high risk for STDs are not getting tested—and don’t ...

According to the Centers for Disease Control and Prevention (CDC) chlamydia and gonorrhea prevail as the two most common STIs with over 2 million cases in the U.S annually. 3 These infections can be ...

Background ACCEPt, a large cluster randomized control trial, aims to determine if annual testing for 16 to 29 year olds in general practice can reduce chlamydia prevalence. ACCEPt is the first trial ...